<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E65D5505-6DF9-4801-9019-B9EDE5D0EE5D"><gtr:id>E65D5505-6DF9-4801-9019-B9EDE5D0EE5D</gtr:id><gtr:name>University Medical Center Gronigen</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Therapeutics</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E65D5505-6DF9-4801-9019-B9EDE5D0EE5D"><gtr:id>E65D5505-6DF9-4801-9019-B9EDE5D0EE5D</gtr:id><gtr:name>University Medical Center Gronigen</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/737D64F9-E64B-425C-9770-408222FAC8AE"><gtr:id>737D64F9-E64B-425C-9770-408222FAC8AE</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Sayers</gtr:surname><gtr:orcidId>0000-0001-5601-5410</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400283"><gtr:id>B1E8C3FF-42B6-4483-85A9-BBB6295308B3</gtr:id><gtr:title>Identification of asthma susceptibility genes on chromosome 19q13</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400283</gtr:grantReference><gtr:abstractText>Asthma is a major cause of human suffering worldwide. Asthma runs in families and has a clear genetic component that leads to the development of disease. A greater understanding of why some people develop asthma and some do not will lead to a greater understanding of the disease, allow treatment to be targetted at those most at risk and provide new targets for drugs to treat asthma.

At this time we do not fully understand what in peoples DNA causes them to develop asthma; however parts of the human genome (all of our genetic material) that might be important have been identified. Our genome is divided into smaller parts called chromosomes. Part of one of these chromosomes; chromosomal region 19q13 has been shown to be involved in asthma susceptibility, but this region is large and the specific parts of the region involved have not been defined. 

The aim of this project is to narrow this region and identify potential genes that may be involved in asthma susceptibility. I will use genetic methods to follow how genetic material is passed from generation to generation in families that have asthmatic children (we have DNA from over 400 families). This information can be used to further define the region we should be looking in for asthma related genes. Once we have this information, potential candidate genes will be analysed for polymorphism (changes in our DNA) and they will be tested to see if they cause an individual to be more likely to develop asthma. If we identify a gene polymorphism that seems to predict the development of asthma we will see if that gene is turned on more in asthmatic vs. non asthmatic tissue and begin studies to understand the role of these genes in asthma.

This project has the potential to identify novel asthma susceptibility genes, identify disease pathways and provide new targets for therapeutic intervention in asthma.</gtr:abstractText><gtr:technicalSummary>Introduction: Asthma is a major cause of human suffering worldwide. Asthma is a complex, multifactorial respiratory disease with both genetic and environmental factors leading to disease expression. 
Chromosomal region 19q13 has shown linkage to asthma per se or bronchial hyperresponsiveness (BHR) in seven independent studies. The region identified to date is large (38.5cM, 35.1-58.4Mbps) making gene identification difficult. Within this region exists two clusters of linkage; Region 1 (46.8-49.1Mbps) and Region 2 (57.3-58.4Mbps).

Aims and Relevance: I propose to further define the linkage peaks observed in Region 1 and Region 2 on chromosome 19q13 and identify and evaluate the functional role of polymorphism in key candidate genes in asthma susceptibility and pathogenesis. This study has the potential to identify novel asthma susceptibility genes and disease pathways. This information may lead to new directions for therapeutic intervention in asthma. 

Experimental Plan: Linkage to Region 1 and Region 2 will be further defined using nine polymorphic microsatellite markers spanning these regions. These markers will be genotyped in a primary asthmatic cohort (65 families, concordant sib pairs) and a secondary asthmatic cohort (341 families, concordant sib pairs). Fine mapping will be used to refine the region of asthma linkage and identify key potential candidate genes from each region. Single nucleotide (SNP) polymorphism will be identified in candidate genes and ten SNPs spanning each gene will be genotyped and evaluated for association with asthma related phenotypes in the families. Association studies will also be completed in an independent case control cohort (500 asthmatics, 500 non-asthmatics). Positive associations will initiate functional studies to investigate the role of these genes/polymorphisms in asthma. Key collaborators include; Professor I. P. Hall (Asthma genetics/respiratory disease), Dr. P. Tighe (High throughput genomics) and Dr. J. W. Holloway (Asthma Genetics/University of Southampton). 

This project will confirm and refine the region of linkage observed on 19q13 for asthma and potentially identify novel genes involved in asthma susceptibility leading to new directions in asthma research/intervention.</gtr:technicalSummary><gtr:fund><gtr:end>2008-05-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-12-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>218929</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>John Holloway (University of Southampton)</gtr:description><gtr:id>A3A5BF0D-35CF-41A5-AD4A-DDA03ACBE038</gtr:id><gtr:impact>We have now published several manuscipts together on MRC and non-MRC funded projects and currently have several joint grant applications.</gtr:impact><gtr:outcomeId>89A9DFB4455-1</gtr:outcomeId><gtr:partnerContribution>Dr Holloway was a named collaborator on the original MRC grant and provided access to his asthma family cohorts for asthma gene discovery.</gtr:partnerContribution><gtr:piContribution>Following access to the DNA we provided statistical analyses of data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Gronigen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Gerard Koppelman (University of Groningen)</gtr:description><gtr:id>0924AA4C-C51F-4499-8769-FEEE514F39F3</gtr:id><gtr:impact>We have now published two manuscripts together and envisage further similar outputs including joint grant applications.</gtr:impact><gtr:outcomeId>016A7A6F2B6-1</gtr:outcomeId><gtr:partnerContribution>Dr Koppelman made his DNA cohort samples and serum samples available to us in the primary analyses for replication. We now coolaborate on a wide range of projects including genetics and primary airway cell analyses.</gtr:partnerContribution><gtr:piContribution>While we have been particularly interested in mapping asthma genes on chromosome 19, Dr Koppelman has been running a similar project on chromosome 5. we provide molecular biology (gene chracterisation) support for this project.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>149664</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK funding (The role of Urokinase Plasminogen Activator Receptor in Epithelial Dysfunction and Asthma)</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>924DD988-F9EC-461F-92A7-073AA01FEDD2</gtr:id><gtr:outcomeId>C2C3B4A71980</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6C05C9B6-C3F2-41F4-B573-D6350927E918</gtr:id><gtr:title>Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells.</gtr:title><gtr:parentPublicationTitle>BMC molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83899bf3ec69b39ee5b959d2ed2a1d5f"><gtr:id>83899bf3ec69b39ee5b959d2ed2a1d5f</gtr:id><gtr:otherNames>Stewart CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2199</gtr:issn><gtr:outcomeId>3EC10F5A8B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>583BD09A-0F23-4A3B-B43C-F683FC1FF042</gtr:id><gtr:title>PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7a72dbc1f98db9c87078e99cac6f544"><gtr:id>f7a72dbc1f98db9c87078e99cac6f544</gtr:id><gtr:otherNames>Barton SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>4176E5DFE1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7535AA1A-8077-44B9-961B-5A5CB47B7DD0</gtr:id><gtr:title>PLAUR polymorphisms and lung function in UK smokers.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83899bf3ec69b39ee5b959d2ed2a1d5f"><gtr:id>83899bf3ec69b39ee5b959d2ed2a1d5f</gtr:id><gtr:otherNames>Stewart CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>B905E9A824E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91F0D619-FA4A-4FA7-820B-A1B33A9DB271</gtr:id><gtr:title>Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f48f5164fcd454d92463e269733a2c50"><gtr:id>f48f5164fcd454d92463e269733a2c50</gtr:id><gtr:otherNames>Ierodiakonou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>56d5b6ba363c52.85871908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0272DA02-3CAF-4377-8B27-FBD45DC1E45F</gtr:id><gtr:title>Atopy susceptibility and chromosome 19q13.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28951db76a9f81ac234722613fce9583"><gtr:id>28951db76a9f81ac234722613fce9583</gtr:id><gtr:otherNames>Holloway JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>66CFC31D0F1</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400283</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>